Thesharp criticism from Glyn Davies, the chief US delegate to theInternational Atomic Energy Agency (IAEA), came a day after Iran beganenriching its uranium to a higher level, increasing internationalconcerns about its nuclear aims.
"Why is Teherangambling with the health and lives of 850,000 Iranian cancer patientsin pursuit of ever more dangerous nuclear technology?" asked Davies.
"This move is callous and chilling," he told The Associated Press.